Veli‐Pekka Harjola

13.5k total citations · 2 hit papers
70 papers, 3.0k citations indexed

About

Veli‐Pekka Harjola is a scholar working on Cardiology and Cardiovascular Medicine, Biomedical Engineering and Emergency Medicine. According to data from OpenAlex, Veli‐Pekka Harjola has authored 70 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Cardiology and Cardiovascular Medicine, 25 papers in Biomedical Engineering and 23 papers in Emergency Medicine. Recurrent topics in Veli‐Pekka Harjola's work include Heart Failure Treatment and Management (29 papers), Mechanical Circulatory Support Devices (23 papers) and Cardiac Arrest and Resuscitation (19 papers). Veli‐Pekka Harjola is often cited by papers focused on Heart Failure Treatment and Management (29 papers), Mechanical Circulatory Support Devices (23 papers) and Cardiac Arrest and Resuscitation (19 papers). Veli‐Pekka Harjola collaborates with scholars based in Finland, Spain and France. Veli‐Pekka Harjola's co-authors include Johan Lassus, Alexandre Mebazaa, Markku S. Nieminen, Gerasimos Filippatos, Petar Seferović, Marco Metra, John Parissis, Tuukka Tarvasmäki, Andrew J.S. Coats and Frank Ruschitzka and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and Scientific Reports.

In The Last Decade

Veli‐Pekka Harjola

66 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Use of Diuretics in Heart Failure with Congestion — A Position Statement from the Heart Failure Association of the European Society of Cardiology

2019 628 citations Wilfried Müllens, Kevin Damman et al. European Journal of Heart Failure profile →
Risk Stratification for Patients in Cardiogenic Shock After Acute Myocardial Infarction

2017 260 citations Johan Lassus, Veli‐Pekka Harjola et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Veli‐Pekka Harjola Finland	26	1.9k	846	749	704	526	70	3.0k
Veli‐Pekka Harjola Finland	23	2.3k 1.2×	725 0.9×	687 0.9×	605 0.9×	406 0.8×	43	3.2k
Amit P. Amin United States	29	1.5k 0.8×	572 0.7×	1.3k 1.7×	577 0.8×	684 1.3×	110	3.2k
Jindřich Špinar Czechia	24	2.2k 1.1×	603 0.7×	928 1.2×	518 0.7×	253 0.5×	117	3.1k
Karim Bendjelid Switzerland	29	1.2k 0.6×	1.0k 1.2×	1.7k 2.3×	554 0.8×	526 1.0×	164	3.0k
Valentina Carubelli Italy	25	1.5k 0.8×	739 0.9×	618 0.8×	594 0.8×	394 0.7×	58	2.4k
Serafina Valente Italy	30	2.5k 1.3×	350 0.4×	1.3k 1.7×	417 0.6×	542 1.0×	162	3.7k
Marco Chiostri Italy	23	1.1k 0.6×	350 0.4×	486 0.6×	305 0.4×	268 0.5×	123	1.9k
Dhaval Kolte United States	33	2.7k 1.4×	639 0.8×	1.4k 1.9×	660 0.9×	680 1.3×	162	4.0k
Morimasa Takayama Japan	31	2.8k 1.4×	348 0.4×	1.2k 1.6×	474 0.7×	477 0.9×	254	3.8k
Amanda Stebbins United States	33	2.8k 1.4×	473 0.6×	961 1.3×	415 0.6×	360 0.7×	81	3.3k

Countries citing papers authored by Veli‐Pekka Harjola

Since Specialization

Citations

This map shows the geographic impact of Veli‐Pekka Harjola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Veli‐Pekka Harjola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Veli‐Pekka Harjola more than expected).

Fields of papers citing papers by Veli‐Pekka Harjola

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Veli‐Pekka Harjola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Veli‐Pekka Harjola. The network helps show where Veli‐Pekka Harjola may publish in the future.

Co-authorship network of co-authors of Veli‐Pekka Harjola

This figure shows the co-authorship network connecting the top 25 collaborators of Veli‐Pekka Harjola. A scholar is included among the top collaborators of Veli‐Pekka Harjola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Veli‐Pekka Harjola. Veli‐Pekka Harjola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tolppanen, Heli, Mercedes Rivas‐Lasarte, Tuukka Tarvasmäki, et al.. (2025). Validation of a Biomarker-Based Mortality Score for Cardiogenic Shock Patients: Comparison with a Clinical Risk Score. ESC Heart Failure. 12(3). 2157–2165. 1 indexed citations

Padró, Teresa, Rosa Suades, Jordi Sans‐Roselló, et al.. (2024). miR‐619‐5p and cardiogenic shock in patients with ST‐segment elevation myocardial infarction. European Journal of Clinical Investigation. 54(8). e14186–e14186.

Strandberg, Timo, et al.. (2022). Low body temperature and mortality in older patients with frailty in the emergency department. Aging Clinical and Experimental Research. 34(6). 1453–1457. 3 indexed citations

Ebner, Matthias, Veli‐Pekka Harjola, Héctor Bueno, et al.. (2021). Venous lactate improves the prediction of in-hospital adverse outcomes in normotensive pulmonary embolism. European Journal of Internal Medicine. 86. 25–31. 19 indexed citations

Tarvasmäki, Tuukka, Veli‐Pekka Harjola, John Parissis, et al.. (2019). Hypoalbuminemia is a frequent marker of increased mortality in cardiogenic shock. PLoS ONE. 14(5). e0217006–e0217006. 46 indexed citations

Müllens, Wilfried, Kevin Damman, Veli‐Pekka Harjola, et al.. (2019). The Use of Diuretics in Heart Failure with Congestion — A Position Statement from the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure. 21(2). 137–155. 628 indexed citations breakdown →

Rueda, Ferran, Eva Borràs, Cosme García‐García, et al.. (2019). Protein-based cardiogenic shock patient classifier. European Heart Journal. 40(32). 2684–2694. 36 indexed citations

Tolppanen, Heli, Tuukka Tarvasmäki, Johan Lassus, et al.. (2018). Circulating Levels of MicroRNA 423-5p are Associated with 90 day Mortality in Cardiogenic Shock. ESC Heart Failure. 6(1). 98–102. 14 indexed citations

Miró, Óscar, Patricia Javaloyes, Víctor Gil, et al.. (2018). Comparative Analysis of Short-Term Outcomes of Patients With Heart Failure With a Mid-Range Ejection Fraction After Acute Decompensation. The American Journal of Cardiology. 123(1). 84–92. 9 indexed citations

10.

Miró, Óscar, Francisco Javier Martín‐Sánchez, Javier Jacob, et al.. (2018). Short-term outcomes of heart failure patients with reduced and preserved ejection fraction after acute decompensation according to the final destination after emergency department care. Clinical Research in Cardiology. 107(8). 698–710. 16 indexed citations

11.

Tolppanen, Heli, Mercedes Rivas‐Lasarte, Johan Lassus, et al.. (2017). Adrenomedullin: a marker of impaired hemodynamics, organ dysfunction, and poor prognosis in cardiogenic shock. Annals of Intensive Care. 7(1). 6–6. 60 indexed citations

12.

Pollesello, Piero, John Parissis, Matti Kivikko, & Veli‐Pekka Harjola. (2016). Levosimendan meta-analyses: Is there a pattern in the effect on mortality?. International Journal of Cardiology. 209. 77–83. 62 indexed citations

13.

Tarvasmäki, Tuukka, Johan Lassus, José Silva‐Cardoso, et al.. (2016). The association of admission blood glucose level with the clinical picture and prognosis in cardiogenic shock – Results from the CardShock Study. International Journal of Cardiology. 226. 48–52. 39 indexed citations

14.

Tarvasmäki, Tuukka, Johan Lassus, Marjut Varpula, et al.. (2016). Current real-life use of vasopressors and inotropes in cardiogenic shock - adrenaline use is associated with excess organ injury and mortality. Critical Care. 20(1). 208–208. 122 indexed citations

15.

Lassus, Johan, Tuukka Tarvasmäki, Alessandro Sionís, et al.. (2016). Use of noninvasive and invasive mechanical ventilation in cardiogenic shock: A prospective multicenter study. International Journal of Cardiology. 230. 191–197. 25 indexed citations

16.

Tarvasmäki, Tuukka, Veli‐Pekka Harjola, Markku S. Nieminen, et al.. (2014). Acute Heart Failure With and Without Concomitant Acute Coronary Syndromes: Patient Characteristics, Management, and Survival. Journal of Cardiac Failure. 20(10). 723–730. 25 indexed citations

17.

Postmus, Douwe, Dirk J. van Veldhuisen, Tiny Jaarsma, et al.. (2011). The COACH Risk Engine: A Multistate Model for Predicting Survival and Hospitalization in Patients with Heart Failure. European Journal of Heart Failure. 14(2). 168–175. 43 indexed citations

18.

Mebazaa, Alexandre, Mihai Gheorghiade, Ileana L. Piña, et al.. (2008). Practical recommendations for prehospital and early in-hospital management of patients presenting with acute heart failure syndromes. Critical Care Medicine. 36(Suppl). S129–S139. 182 indexed citations

19.

Nieminen, Markku S., Veli‐Pekka Harjola, Matthias Hochadel, et al.. (2008). Gender Related Differences in Patients Presenting with Acute Heart Failure. Results from EuroHeart Failure Survey II. European Journal of Heart Failure. 10(2). 140–148. 130 indexed citations

20.

Rudiger, Alain, Veli‐Pekka Harjola, Andreas Müller, et al.. (2005). Acute Heart Failure: Clinical Presentation, One-Year Mortality and Prognostic Factors. European Journal of Heart Failure. 7(4). 662–670. 134 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact